BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28281102)

  • 1. Glutamine Addiction In Gliomas.
    Márquez J; Alonso FJ; Matés JM; Segura JA; Martín-Rufián M; Campos-Sandoval JA
    Neurochem Res; 2017 Jun; 42(6):1735-1746. PubMed ID: 28281102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
    Li C; Zhang G; Zhao L; Ma Z; Chen H
    World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma.
    Trejo-Solis C; Silva-Adaya D; Serrano-García N; Magaña-Maldonado R; Jimenez-Farfan D; Ferreira-Guerrero E; Cruz-Salgado A; Castillo-Rodriguez RA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamine Metabolism in Gliomas.
    Szeliga M; Albrecht J
    Adv Neurobiol; 2016; 13():259-273. PubMed ID: 27885632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of exogenous lactate on rat glioma metabolism.
    Bouzier-Sore AK; Canioni P; Merle M
    J Neurosci Res; 2001 Sep; 65(6):543-8. PubMed ID: 11550222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction.
    Fogal V; Babic I; Chao Y; Pastorino S; Mukthavaram R; Jiang P; Cho YJ; Pingle SC; Crawford JR; Piccioni DE; Kesari S
    Oncotarget; 2015 Jan; 6(2):1157-70. PubMed ID: 25528767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of dysregulated glutamine metabolism in human glioma tissue with
    Ekici S; Risk BB; Neill SG; Shu HK; Fleischer CC
    Sci Rep; 2020 Nov; 10(1):20435. PubMed ID: 33235296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer.
    Matés JM; Di Paola FJ; Campos-Sandoval JA; Mazurek S; Márquez J
    Semin Cell Dev Biol; 2020 Feb; 98():34-43. PubMed ID: 31100352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-scale computational study of the Warburg effect, reverse Warburg effect and glutamine addiction in solid tumors.
    Shan M; Dai D; Vudem A; Varner JD; Stroock AD
    PLoS Comput Biol; 2018 Dec; 14(12):e1006584. PubMed ID: 30532226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells.
    Smith B; Schafer XL; Ambeskovic A; Spencer CM; Land H; Munger J
    Cell Rep; 2016 Oct; 17(3):821-836. PubMed ID: 27732857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas.
    Martins F; Gonçalves LG; Pojo M; Serpa J
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32993063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.
    Venneti S; Dunphy MP; Zhang H; Pitter KL; Zanzonico P; Campos C; Carlin SD; La Rocca G; Lyashchenko S; Ploessl K; Rohle D; Omuro AM; Cross JR; Brennan CW; Weber WA; Holland EC; Mellinghoff IK; Kung HF; Lewis JS; Thompson CB
    Sci Transl Med; 2015 Feb; 7(274):274ra17. PubMed ID: 25673762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.
    Daye D; Wellen KE
    Semin Cell Dev Biol; 2012 Jun; 23(4):362-9. PubMed ID: 22349059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
    Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
    Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer.
    Akins NS; Nielson TC; Le HV
    Curr Top Med Chem; 2018; 18(6):494-504. PubMed ID: 29788892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose Addiction in Cancer Therapy: Advances and Drawbacks.
    Granja S; Pinheiro C; Reis RM; Martinho O; Baltazar F
    Curr Drug Metab; 2015; 16(3):221-42. PubMed ID: 26504932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.
    Ziegler A; von Kienlin M; Décorps M; Rémy C
    Cancer Res; 2001 Jul; 61(14):5595-600. PubMed ID: 11454713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer.
    Delgir S; Bastami M; Ilkhani K; Safi A; Seif F; Alivand MR
    Mutat Res Rev Mutat Res; 2021; 787():108366. PubMed ID: 34083056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Glutamine Addiction in Gliomas.
    Obara-Michlewska M; Szeliga M
    Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 32013066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carnosine suppresses human glioma cells under normoxic and hypoxic conditions partly via inhibiting glutamine metabolism.
    Fang YJ; Wu M; Chen HN; Wen TT; Lyu JX; Shen Y
    Acta Pharmacol Sin; 2021 May; 42(5):767-779. PubMed ID: 32782394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.